Rolf Watter
Europe Guide 2024
Band 1 : Corporate/M&A
Email address
[email protected]Contact number
+41 58 261 5000Share profile
Band 1
About
Provided by Rolf Watter
Practice Areas
Rolf Watter heads the M&A-Transaction practice at Bär & Karrer. He is based in Zurich and Partner since 1994. He has broad experience in all types of M&A transactions, including defence mandates. He also specializes in corporate governance questions and capital market transactions. Rolf Watter is presently chairman of PostFinance AG and a board member of Aryzta AG, AP Alternative Portfolio and of the privately held Faber Castell (Holding) AG. Rolf Watter used to be a board member in a number of Swiss listed companies, namely Ceva Logistics and Nobel Biocare (chairman in both), Zurich Insurance, Syngenta, Centrepulse and Forbo.
Career
University of Zurich: Dr. iur. (1985), Admitted at the Zurich Bar (1986), Georgetown University, Washington D.C.: LL.M. (1988), Professor at the University of Zurich since 1996.
Professional Memberships
Swiss Bar Association, Zurich Bar Association, Member of the Regulatory Board of the SIX Swiss Exchange.
Publications
He is an editor of the GesKR and the Basler Kommentare on the Code of Obligations II, the Financial Infrastructure Act, the Banking and the Merger Act. He regularly publishes in this fields of work.
Personal
Rolf Watter speaks German, English and French
Chambers Review
Europe
Rolf Watter is a highly established practitioner handling transatlantic and pan-European spin-offs and acquisitions, as well as advising on restructuring mandates.
Articles, highlights and press releases
4 items provided by Bär & Karrer Ltd
Bär & Karrer Advises Lupa in Connection with a Rights Offering of MCH Group
Bär & Karrer Advises Lupa in Connection with a Rights Offering of MCH Group
Bär & Karrer Advises Firmenich in its Merger with DSM
Bär & Karrer, together with the Dutch law firm Stibbe, acts as legal advisor to Firmenich in its merger with DSM.
Bär & Karrer Advises AC Immune on the Strategic Acquisition of Industry-leading Parkinson's Disease
Bär & Karrer Advises AC Immune on the Strategic Acquisition of Industry-leading Parkinson's Disease Vaccine Candidate and Equity Investment
Bär & Karrer Advises Swiss International Air Lines and Edelweiss Air on its CHF 1.5 Billion Credit
Swiss International Air Lines AG and Edelweiss Air AG have entered into a CHF 1.5 billion revolving credit facility agreement with Credit Suisse (Schweiz) AG and UBS Switzerland AG as mandated lead arrangers, coordinators and lenders and additional banks as part of a syndicate.
Bär & Karrer Advises Lupa in Connection with a Rights Offering of MCH Group
Bär & Karrer Advises Lupa in Connection with a Rights Offering of MCH Group
Bär & Karrer Advises Firmenich in its Merger with DSM
Bär & Karrer, together with the Dutch law firm Stibbe, acts as legal advisor to Firmenich in its merger with DSM.
Bär & Karrer Advises AC Immune on the Strategic Acquisition of Industry-leading Parkinson's Disease
Bär & Karrer Advises AC Immune on the Strategic Acquisition of Industry-leading Parkinson's Disease Vaccine Candidate and Equity Investment
Bär & Karrer Advises Swiss International Air Lines and Edelweiss Air on its CHF 1.5 Billion Credit
Swiss International Air Lines AG and Edelweiss Air AG have entered into a CHF 1.5 billion revolving credit facility agreement with Credit Suisse (Schweiz) AG and UBS Switzerland AG as mandated lead arrangers, coordinators and lenders and additional banks as part of a syndicate.
Discover other Lawyers at
Bär & Karrer Ltd
Switzerland
